Nutritional Medicine Journal

The Nutritional Medicine Journal (NMJ) is a specialist peer-reviewed scientific publication related to the application of personalised dietary interventions, foods, dietary factors, and nutritional supplements in clinical practice.

Topics include clinical nutrition, personalised nutrition, lifestyle medicine, micronutrients, amino acids, fatty acids, phytochemicals, probiotics, prebiotics, and functional beverages and foods. The aim of the NMJ is to provide health professionals with authoritative and scientifically accurate articles on topics in nutritional medicine.

Latest Issue

March 2022. VOL, 1. NO,1.

Latest Articles

Collagen: A Review of Clinical Use and Efficacy

Orally administered collagen in its many different forms is recognised as a highly biocompatible, safe form of supplementation, which has the potential to act on the body as an anti-inflammatory and antioxidant, and through structural remodelling and reduced lipotoxicity. The aim of this systematic review was to determine diseases where collagen has been indicated; assess safety, bioavailability and efficacy; and to provide therapeutic recommendations. It was concluded that collagen supplementation is strongly indicated for its positive therapeutic effect on pain management of osteoarthritis, balancing blood sugars in type II diabetes, wound healing, skin ageing, and post-exercise body composition and strength. Promising results were also seen for the use of collagen supplementation in osteoporosis, hypertension, rheumatoid arthritis, tendinopathy, cellulite, atopic dermatitis, sarcopenia and brittle nail syndrome. Although therapeutic recommendations were indicated in most of these diseases, owing in the large part to the use of these supplements as part of dual therapy or the uncertainty over translatability of branded products it was concluded that more studies are required to make definitive recommendations. There was a lack of clinical evidence to support the use of collagen for weight loss in obesity, gut health and in fibromyalgiaFull Article

Cite as: Steele, C. (2022) Collagen: a review of clinical use and efficacy. Nutr Med J. 2022 Jul; 1 (2): xxx

Vitamin D: A Review of Clinical Use and Efficacy

Vitamin D3 is produced in the skin on exposure to ultraviolet B radiation, and is metabolised in the liver and kidneys to the biologically active form of vitamin D that binds to vitamin D receptors. Vitamin D was first recognised for its importance in calcium metabolism and therefore bone health, with the classic deficiency disease being rickets in children and osteomalacia in adults, but is now also known for its importance in modulating immunity.

Epidemiological studies have linked vitamin D deficiency to many conditions, including heart disease, cancer, allergies and autoimmunity. Vitamin D supplementation trials have confirmed benefits for some conditions, including atopic dermatitis, chronic urticaria, colorectal cancer, depression, polycystic ovary syndrome and type 2 diabetes mellitus, but not others, such as multiple sclerosis, prevention of allergic sensitisation in infants and psoriasis. Whilst there is some evidence of benefits for cardiovascular risk factors, this does not translate to a reduction in cardiovascular events in clinical trials.

Vitamin D is generally considered safe, and the upper limit set by the National Institute of Health is 4000 IU per day. The main safety concern with vitamin D is hypercalcaemia, based on its role in calcium metabolism, and caution is therefore advised in conditions and with medications that can also affect calcium metabolism. Full Article

Cite as: Elgar, K. Vitamin D: A Review of Clinical Use and Efficacy. Nutr Med J. 2022 Jul; 1 (2): xxx

EPA / DHA: A Review of Clinical Use and Efficacy

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 polyunsaturated fatty acids found in oily fish. Humans can also synthesise them from α-linolenic acid (ALA), which is considered an essential fatty acid as humans cannot synthesise it. However, conversion of ALA to EPA and DHA tends to be low, with significant inter-individual variation, making them conditionally essential nutrients. The benefits of EPA and DHA for cardiovascular health were first recognised in the 1970s. Since then, research has shown benefits in many other conditions, including metabolic, inflammatory and neuropsychiatric disorders, based on their anti-inflammatory and antioxidant effects, as well as their roles in cell membrane structure and function and in regulating gene expression. Fish oil supplements are generally well tolerated, but increased risk of atrial fibrillation and bleeding have been found in several meta-analysesFull Article

Cite as: Elgar, K. (2022) EPA/DHA: A Review of Clinical Use and Efficacy. Nutr. Med J., 2 (2), xxx.

Resveratrol: A Review of Clinical Use and Efficacy

Resveratrol is a polyphenol found in many plant foods, and in particularly high concentrations in red wine. Epidemiological studies have shown significant reductions in all-cause mortality with dietary patterns high in resveratrol, and preclinical research has identified a number of anti-inflammatory, antioxidant, anti-cancer and cardioprotective mechanisms of resveratrol. 

Resveratrol has been studied in a number of conditions, including Alzheimer’s disease, cognitive function, cardiometabolic conditions, osteoporosis, autoimmunity and for cancer prevention. For most clinical uses, studies are limited and conflicting results have been observed. The range of dosages used in clinical trials has also varied widely and there are some suggestions of a non-linear dose−response relationship, with high dosages potentially harmful. More clinical research is needed for practitioners to base their recommendations on. Full Article

Cite as: Elgar K. (2021) Resveratrol: A review of clinical use and efficacy. Nutr. Med. J., Jul; 2 (2): xxx

Nutritional Medicine in Primary Healthcare

Dietary interventions and nutrient-based supplements can prevent disease, reverse established illness and improve health while being very safe and, in some cases, extraordinarily effective. Yet the scientific evidence for nutritional medicine is not well incorporated into medical training, and consequently nutritional therapy is underutilised in clinical practice to the detriment of good patient care. Full Article

Brown, B. (2022) Nutritional medicine in primary healthcare.Nutr. Med. J., 1 (1), 6-9.

Butyrate Therapy for Treatment-Resistant Ulcerative Colitis: A Case Study

A number of patients with ulcerative colitis (UC) fail to achieve clinical remission with standard treatments, and may become less responsive to these treatments over time. Butyrate, a short-chain fatty acid, plays a major role in the immune homeostasis of the colonic mucosa, and oral butyrate has shown some promise as an adjuvant therapy in a small number of clinical studies, including for treatment-resistant patients. This case report describes an individual with a diagnosis of UC resistant to pharmacological and nutritional interventions who responded well to a trial of oral butyrate. Butyrate appears to be a promising therapy for UC, but questions around its efficacy, personalisation and safety require further investigation. Full Article

Gibbs, B. & Brown, B. (2021) Butyrate therapy for treatment-resistant ulcerative colitis: a case study. Nutr. Med. J., 1 (1), 60-67.

Inflammatory Bowel Disease: Towards a Model for Personalised Nutritional Therapy

Inflammatory bowel disease (IBD) has a complex multifactorial aetiology involving interactions between environmental factors (including diet), the microbiome, genetics and the immune system, leading to dysfunctional immune responses and chronic inflammation. Dietary factors and gut dysbiosis have emerged as important treatment targets in the management of IBD as they are involved in the initiation and perpetuation of inflammation, and subsequently disease development and progression. Specific dietary approaches and nutritional interventions have some, albeit limited, clinical evidence to suggest they can modify gene expression, have anti-inflammatory effects, induce mucosal healing, normalise intestinal microbiota, reduce disease activity and/or help maintain remission. This review uses evidence from nutritional science to propose a theoretical pragmatic model for the personalisation of nutritional therapy in patients with active or latent IBD, incorporating disease-modifying dietary recommendations and nutrient-based supplements, primarily as adjuvant therapies, with the intention to stimulate further investigation and research. Full Article

Brown, B. (2022) Inflammatory bowel disease: towards a model for personalised nutritional therapy. Nutr. Med. J., 1 (1), 32-59.

Sulforaphane, 3,3'-Diindolylmethane and Indole-3-Carbinol: A Review of Clinical Use and Efficacy

Sulforaphane (SFN), 3,3′-diindolylmethane (DIM) and indole-3-carbinol (I3C, a precursor of DIM) are compounds that are obtained through eating cruciferous vegetables, which have been shown in epidemiological studies to have health benefits. SFN and DIM have been shown to have antioxidant, anti-inflammatory and anti-cancer effects, as well as playing important roles in cellular detoxification of xenobiotics through their effects on nuclear factor-kappa B (NF-kB) and nuclear factor erythroid 2-related factor 2 (Nrf2). DIM and I3C have also been shown to affect oestrogen metabolism. In view of these properties, SFN, DIM and I3C have been studied in clinical trials and, although clinical research is still limited, promising results have been seen in a number of health conditions. Full Article

Elgar, K. (2022) Sulforaphane (SFN), 3,3′-diindolylmethane (DIM) and indole-3-carbinol (I3C): A Review of Clinical Use and Efficacy. Nutr. Med. J. 2022 Jul; 1 (2): xxx

Ashwagandha: A Review of Clinical Use and Efficacy

Ashwagandha has a long tradition of use in Ayurvedic medicine, and is best known as an adaptogen, a compound that can help increase our resistance to stress. Preclinical research has also shown ashwagandha to have anti-inflammatory, antimicrobial, antioxidant, antidiabetic, anti-tumour, anti-ageing and neuroprotective properties. Steroidal alkaloids and lactones, including withaferin A and withanolides, are thought to be some of the most active compounds of the herb. Clinical research in humans has shown ashwagandha to be safe and of benefit in a range of conditions, including stress/anxiety, athletic performance, cognition, diabetes, insomnia and male infertility. Ashwagandha is generally considered to be safe, with a few minor possible side-effects, although care should be taken alongside certain drugs. Full Article

Cite as: Elgar K. Ashwagandha: A Review of Clinical Use and Efficacy. Nutr Med J. 2021 Mar; 1 (1): 68-78

Coenzyme Q10: A Review of Clinical Use and Efficacy

Coenzyme Q10 (CoQ10) plays an essential role in energy production as part of the mitochondrial electron transfer chain. It also has antioxidant functions and is important for gene regulation, especially of genes involved in cell signalling, metabolism, inflammation, transport and transcription control. Whilst we can obtain small amounts from our diet, most CoQ10 is synthesised in our bodies, which is why it is not considered to be a vitamin. Production declines with age and may also be impaired through illness and/or certain medications, making supplementation an interesting intervention. Although clinical research has been mixed in some indications, CoQ10 supplementation has been found to be a safe and effective intervention in a variety of conditions, including cardiometabolic disorders, fibromyalgia syndrome, migraine and male infertility. Full Article

Cite as (AMA): Elgar K. (2021) Coenzyme Q10: A Review of Clinical Use and Efficacy. Nutr Med J. 2022 Mar; 1 (1): 100-118.

Curcumin: A Review of Clinical Use and Efficacy

Turmeric has a long tradition of use in Ayurvedic medicine for a variety of indications, including digestive and liver support, in mood-related disorders and inflammatory conditions. Modern research has confirmed anti-inflammatory, antioxidant, anti-microbial and anti-tumour activities of compounds isolated from turmeric, including curcumin and other curcuminoids. Curcumin has poor bioavailability and various formulations have therefore been developed to overcome this issue. Clinical trials have shown benefits of curcuminoids in a wide range of conditions, including cardiometabolic, inflammatory and mood disorders. Turmeric extracts have been found to be safe in humans with only mild adverse events being observed in clinical trials, mostly gastrointestinal disturbances, but due to its physiological actions, some drug interactions are possible. Full Article

Cite as (AMA): Elgar K. Curcumin: A Review of Clinical Use and Efficacy. Nutr Med J. 2022 Mar; 1 (1): 10-31.

Magnesium: A Review of Clinical Use and Efficacy

Magnesium is a co-factor for more than 300 different enzymatic processes, and therefore plays a role in virtually every process in the cell, including cellular energy production, neuromuscular and cardiac function, maintaining ionic gradients, regulation of cell membrane receptors and DNA, RNA and protein synthesis. It is also an essential structural component for DNA and RNA on the cellular level, as well as in bones and teeth.

Whilst overt magnesium deficiency is rare, subclinical deficiency appears to be common, and increases the risk of many chronic conditions. Organic magnesium formulations, such as citrate, have been shown to be slightly better absorbed than inorganic ones, but many clinical trials have used inorganic formulations of magnesium, mostly oxide and chloride, and have shown benefits in a range of conditions, including cardiometabolic conditions, bone health, pain and constipation. Full Article

Cite as: Elgar K. Magnesium: A Review of Clinical Use and Efficacy. Nutr Med J. 2022 Mar; 1 (1): 79-99.